文献速递区域麻醉与超声疼痛医学

术前椎旁阻滞与乳腺癌术后慢性疼痛:双盲随机试验

Preoperative Paravertebral Block and Chronic Pain after Breast Cancer Surgery: A Double-blind Randomized Trial.
PubMed 文献 · Anesthesiology · 2021-01-01

这项多中心双盲随机对照试验纳入380例乳腺癌手术患者,比较术前椎旁阻滞(0.75%罗哌卡因0.35 ml/kg)与生理盐水对术后慢性疼痛的影响。结果显示椎旁阻滞未降低术后3个月慢性疼痛发生率(52.2% vs 47.7%,OR 1.20,95%CI 0.79-1.82,P=0.394),但减少了术后即刻疼痛和吗啡用量。

要点

  • 术前椎旁阻滞未降低乳腺癌术后3个月慢性疼痛发生率。
  • 椎旁阻滞组术后0-2小时静息和最大疼痛评分显著低于对照组。
  • 椎旁阻滞组术后吗啡用量减少73%(OR 0.272,95%CI 0.171-0.429,P<0.001)。

核心结论

  • 椎旁阻滞不能降低乳腺癌术后3个月慢性疼痛的发生率。
  • 椎旁阻滞可减轻术后即刻疼痛并减少吗啡用量,但其他术后结局无显著差异。

研究设计与样本

  • 前瞻性、多中心、随机、双盲、平行组、安慰剂对照研究。
  • 380例接受部分或全乳切除术伴或不伴淋巴结清扫的女性患者随机分组。
  • 椎旁组接受0.35 ml/kg 0.75%罗哌卡因,对照组接受生理盐水,两组均接受全身多模式镇痛。

主要发现

  • 术后3个月慢性疼痛(VAS≥3/10)发生率:椎旁组93/178(52.2%),对照组83/174(47.7%),OR 1.20(95%CI 0.79-1.82),P=0.394。
  • 术后6个月慢性疼痛:椎旁组104/178(58.4%),对照组79/174(45.4%);12个月:椎旁组105/178(59.0%),对照组93/174(53.4%)。
  • 术后0-2小时静息疼痛曲线下面积:椎旁组4.3±2.8 vs 对照组2.9±2.8 VAS单位×小时,P<0.001;最大疼痛评分:3.8±2.1 vs 2.5±2.5,P<0.001。
  • 术后吗啡用量椎旁组减少73%(OR 0.272,95%CI 0.171-0.429,P<0.001)。

临床怎么用

  • 术前椎旁阻滞不应以预防慢性疼痛为目的用于乳腺癌手术。
  • 椎旁阻滞可用于改善术后即刻镇痛并减少阿片类药物用量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effectiveness of paravertebral block in preventing chronic pain after breast surgery remains controversial. The primary hypothesis of this study was that paravertebral block reduces the incidence of chronic pain 3 months after breast cancer surgery. METHODS: In this prospective, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, 380 women undergoing partial or complete mastectomy with or without lymph node dissection were randomized to receive preoperative paravertebral block with either 0.35 ml/kg 0.75% ropivacaine (paravertebral group) or saline (control group). Systemic multimodal analgesia was administered in both groups. The primary endpoint was the incidence of chronic pain with a visual analogue scale (VAS) score greater than or equal to 3 out of 10, 3 months after surgery. The secondary outcomes were acute pain, analgesic consumption, nausea and vomiting, chronic pain at 6 and 12 months, neuropathic pain, pain interference, anxiety, and depression. RESULTS: Overall, 178 patients received ropivacaine, and 174 received saline. At 3 months, chronic pain was reported in 93 of 178 (52.2%) and 83 of 174 (47.7%) patients in the paravertebral and control groups, respectively (odds ratio, 1.20 [95% CI, 0.79 to 1.82], P = 0.394). At 6 and 12 months, chronic pain occurred in 104 of 178 (58.4%) versus 79 of 174 (45.4%) and 105 of 178 (59.0%) versus 93 of 174 (53.4%) patients in the paravertebral and control groups, respectively. Greater acute postoperative pain was observed in the control group 0 to 2 h (area under the receiver operating characteristics curve at rest, 4.3 ± 2.8 vs. 2.9 ± 2.8 VAS score units × hours, P < 0.001) and when maximal in this interval (3.8 ± 2.1 vs. 2.5 ± 2.5, P < 0.001) but not during any other interval. Postoperative morphine use was 73% less in the paravertebral group (odds ratio, 0.272 [95% CI, 0.171 to 0.429]; P < 0.001). CONCLUSIONS: Paravertebral block did not reduce the incidence of chronic pain after breast surgery. Paravertebral block did result in less immediate postoperative pain, but there were no other significant differences in postoperative outcomes.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Albi-Feldzer A, Dureau S, Ghimouz A, et al. Preoperative Paravertebral Block and Chronic Pain after Breast Cancer Surgery: A Double-blind Randomized Trial. Anesthesiology. 2021. PMID: 34618889. doi:10.1097/ALN.0000000000003989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。